Phase II Study of Nivolumab Plus Ipilimumab with Platinum-Based Chemotherapy for Treatment-Naïve Advanced Non-Small Cell Lung Cancer with Untreated Brain Metastases: NIke Trial (LO...

por Tsuchiya-Kawano, Yuko, Shiraishi, Yoshimasa, Kiyomi, Fumiaki, Okamoto, Isamu
Publicado 2021

Remarkable response to dacomitinib in a patient with leptomeningeal carcinomatosis due to EGFR‐mutant non‐small cell lung cancer

por Mizusaki, Shun, Otsubo, Kohei, Ninomiya, Toshifumi, Arimura, Hidenobu, Tsuchiya‐Kawano, Yuko, Inoue, Koji
Publicado 2020

Forthcoming Phase II Study of Durvalumab (MEDI4736) Plus Chemotherapy for Small Cell Lung Cancer with Brain Metastases

por Shiraishi, Yoshimasa, Shimose, Takayuki, Tsuchiya-Kawano, Yuko, Ishii, Hidenobu, Daga, Haruko, Ito, Kentaro, Saruwatari, Koichi, Okamoto, Isamu
Publicado 2022

Clinical efficacy of dacomitinib in rechallenge setting for patients with epidermal growth factor receptor mutant non–small cell lung cancer: A multicenter retrospective analysis (...

por Tanaka, Hisashi, Sakamoto, Hiroaki, Akita, Takahiro, Ohyanagi, Fumiyoshi, Kawashima, Yosuke, Tambo, Yuichi, Tanimoto, Azusa, Horiike, Atsushi, Miyauchi, Eisaku, Tsuchiya‐Kawano, Yuko, Yanagitani, Noriko, Nishio, Makoto
Publicado 2022

Second-line immunosuppressant administration for steroid-refractory immune-related adverse events in patients with lung cancer

por Ogusu, Shinsuke, Harutani, Yuhei, Tozuka, Takehiro, Saito, Ryota, Koyama, Junji, Sakamoto, Hiroaki, Sonoda, Tomoaki, Tsuchiya-Kawano, Yuko, Oba, Tomohiro, Kudo, Keita, Gyotoku, Hiroshi, Nakatomi, Katsumi, Ariyasu, Ryo
Publicado 2023

Association of thyroid transcription factor-1 (TTF-1) expression with efficacy of PD-1/PD-L1 inhibitors plus pemetrexed and platinum chemotherapy in advanced non-squamous non-small...

por Ibusuki, Ritsu, Yoneshima, Yasuto, Hashisako, Mikiko, Matsuo, Norikazu, Harada, Taishi, Tsuchiya-Kawano, Yuko, Kishimoto, Junji, Ota, Keiichi, Shiraishi, Yoshimasa, Iwama, Eiji, Tanaka, Kentaro, Oda, Yoshinao, Okamoto, Isamu
Publicado 2022

Risk factors for disease progression in Japanese patients with COVID-19 with no or mild symptoms on admission

por Ninomiya, Toshifumi, Otsubo, Kohei, Hoshino, Teppei, Shimokawa, Mototsugu, Nakazawa, Megumi, Sato, Yoriko, Mikumo, Hironori, Kawakami, Satoru, Mizusaki, Shun, Mori, Yusuke, Arimura, Hidenobu, Tsuchiya-Kawano, Yuko, Inoue, Koji, Uchida, Yujiro, Nakanishi, Yoichi
Publicado 2021

A propensity score-matched analysis of the impact of statin therapy on the outcomes of patients with non-small-cell lung cancer receiving anti-PD-1 monotherapy: a multicenter retro...

por Takada, Kazuki, Shimokawa, Mototsugu, Takamori, Shinkichi, Shimamatsu, Shinichiro, Hirai, Fumihiko, Tagawa, Tetsuzo, Okamoto, Tatsuro, Hamatake, Motoharu, Tsuchiya-Kawano, Yuko, Otsubo, Kohei, Inoue, Koji, Yoneshima, Yasuto, Tanaka, Kentaro, Okamoto, Isamu, Nakanishi, Yoichi, Mori, Masaki
Publicado 2022

Clinical efficacy of amrubicin in patients with small cell lung cancer relapse after first‐line treatment including immune checkpoint inhibitors: A retrospective multicenter study...

por Uematsu, Shinya, Kitazono, Satoru, Tanaka, Hisashi, Saito, Ryota, Kawashima, Yosuke, Ohyanagi, Fumiyoshi, Tozuka, Takehiro, Ryosuke, Tsugitomi, Sakatani, Toshio, Horiike, Atsushi, Yoshizawa, Takahiro, Saiki, Masafumi, Tambo, Yuichi, Koyama, Junji, Kanazu, Masaki, Kudo, Keita, Tsuchiya‐Kawano, Yuko, Yanagitani, Noriko, Nishio, Makoto
Publicado 2022

A Phase 2 Single-Arm Study of Osimertinib for Radiotherapy-Naive Central Nervous System Metastasis NSCLC: Results for the First-Line Cohort of the OCEAN Study (LOGIK 1603/WJOG 9116...

por Wakuda, Kazushige, Yamaguchi, Hiroyuki, Kenmotsu, Hirotsugu, Fukuda, Minoru, Ito, Kentaro, Tsuchiya-Kawano, Yuko, Tanaka, Kentaro, Harada, Taishi, Nakatani, Yuki, Miura, Satoru, Yokoyama, Toshihide, Nakamura, Tomomi, Izumi, Miiru, Nakamura, Atsushi, Ikeda, Satoshi, Takayama, Koichi, Yoshimura, Kenichi, Nakagawa, Kazuhiko, Yamamoto, Nobuyuki, Sugio, Kenji
Publicado 2023

A Phase II Trial on Osimertinib as a First-Line Treatment for EGFR Mutation-Positive Advanced NSCLC in Elderly Patients: The SPIRAL-0 Study

por Chihara, Yusuke, Takeda, Takayuki, Goto, Yasuhiro, Nakamura, Yoichi, Tsuchiya-Kawano, Yuko, Nakao, Akira, Onoi, Keisuke, Hibino, Makoto, Fukuda, Minoru, Honda, Ryoichi, Yamada, Takahiro, Taniguchi, Ryusuke, Sakamoto, Sinjiro, Date, Koji, Nagashima, Seiji, Tanzawa, Shigeru, Minato, Koichi, Nakatani, Koichi, Izumi, Miiru, Shimose, Takayuki, Kishimoto, Junji, Uchino, Junji, Takayama, Koichi
Publicado 2022